Finance RXDX Stock Skyrockets On Promising Results In Irritable Bowel DiseaseDecember 7, 20220 Prometheus Biosciences (RXDX) reported promising outcomes for one among its medicine in two inflammatory illness research on Wednesday, and RXDX…
